John Arnold: Trump administration’s good effort on drug rebates is bad policy
ADOBE
The Trump administration's proposal to ban rebates to PBMs is a distraction from a larger debate about how we should pay for drugs.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario